文献速递垂体与肾上腺疾病

多发性内分泌腺瘤病1型患者同侧肾上腺皮质癌与腺瘤中原发性醛固酮增多症的遗传学解析

Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

一例48岁女性多发性内分泌腺瘤病1型(MEN1)患者,因右肾上腺8 cm复杂肿块就诊,确诊原发性醛固酮增多症(PA);右肾上腺切除见4 cm嗜酸细胞性肾上腺皮质癌(ACC)与2.3 cm肾上腺皮质腺瘤共存。基因分析示MEN1胚系致病性变异(c.1556delC, p.Pro519Leufs*40),腺瘤与癌中均丢失野生型MEN1等位基因,仅醛固酮瘤携带KCNJ5体细胞致病性变异(c.451G>A, p.Gly151Arg)。

要点

  • MEN1患者可同时发生嗜酸细胞性ACC与醛固酮瘤,免疫组化示醛固酮合酶蛋白在腺瘤高表达而在ACC不表达。
  • MEN1胚系致病性变异c.1556delC(p.Pro519Leufs*40)在腺瘤与癌中均伴野生型等位基因丢失。
  • KCNJ5体细胞致病性变异c.451G>A(p.Gly151Arg)仅见于醛固酮瘤。

核心结论

  • 据作者所知,本例为首例携带MEN1胚系致病性变异的患者发生肾上腺碰撞瘤,腺瘤与嗜酸细胞性ACC均伴MEN1杂合性缺失,且醛固酮瘤携带KCNJ5体细胞致病性变异。
  • 该病例为MEN1患者肾上腺肿瘤发生机制提供了新见解。

研究设计与样本

  • 个案报告:一例48岁女性MEN1患者,已知原发性甲状旁腺功能亢进和高血压伴低钾血症,因右肾上腺8 cm复杂肿块(18F-FDG PET/CT SUVmax 38.1)转诊。

主要发现

  • 盐水抑制试验证实PA:醛固酮1948 pmol/L降至1675 pmol/L(正常范围:盐水输注后<165),肾素水平受抑(<5 ng/L;正常范围5-20)。
  • 儿茶酚胺、雄激素、24小时尿皮质醇及垂体激素 panel 均正常。
  • 右开放肾上腺切除术发现同时存在4 cm嗜酸细胞性ACC和2.3 cm肾上腺皮质腺瘤。
  • 免疫组化示醛固酮合酶蛋白在腺瘤中高表达而在ACC中不表达,支持醛固酮过量由腺瘤产生。

关键数值与推荐

  • MEN1测序发现胚系致病性变异c.1556delC(p.Pro519Leufs*40),为杂合性。
  • 切除的腺瘤和癌的肿瘤DNA中均丢失野生型MEN1等位基因。
  • PA驱动基因测序显示KCNJ5第2外显子体细胞致病性变异c.451G>A(p.Gly151Arg)仅见于醛固酮瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adrenal tumors are found in up to 40% of patients with multiple endocrine neoplasia type 1 (MEN1). However, adrenocortical carcinomas (ACC) and primary aldosteronism (PA) are rare in MEN1. CASE: A 48-year-old woman known to have primary hyperparathyroidism and hypertension with hypokalemia was referred for a right complex 8-cm adrenal mass with a 38.1 SUVmax uptake on 18F-FDG PET/CT. PA was confirmed by saline suppression test (aldosterone 1948 pmol/L-1675 pmol/L; normal range [N]: <165 post saline infusion) and suppressed renin levels (<5 ng/L; N: 5-20). Catecholamines, androgens, 24-hour urinary cortisol, and pituitary panel were normal. A right open adrenalectomy revealed a concomitant 4-cm oncocytic ACC and a 2.3-cm adrenocortical adenoma. Immunohistochemistry showed high expression of aldosterone synthase protein in the adenoma but not in the ACC, supporting excess aldosterone production by the adenoma. GENETIC ANALYSIS: After genetic counseling, the patient underwent genetic analysis of leucocyte and tumoral DNA. Sequencing of MEN1 revealed a heterozygous germline pathogenic variant in MEN1 (c.1556delC, p.Pro519Leufs*40). The wild-type MEN1 allele was lost in the tumoral DNA of both the resected adenoma and carcinoma. Sequencing analysis of driver genes in PA revealed a somatic pathogenic variant in exon 2 of the KCNJ5 gene (c.451G>A, p.Gly151Arg) only in the aldosteronoma. CONCLUSION: To our knowledge, we describe the first case of adrenal collision tumors in a patient carrying a germline pathogenic variant of the MEN1 gene associated with MEN1 loss of heterozygosity in both oncocytic ACC and adenoma and a somatic KCNJ5 pathogenic variant leading to aldosterone-producing adenoma. This case gives new insights on adrenal tumorigenesis in MEN1 patients.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Parisien-La Salle S, Corbeil G, El-Haffaf Z, et al. Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma. J Clin Endocrinol Metab. 2022. PMID: 36179244. doi:10.1210/clinem/dgac564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。